Catheter Precision, Inc. (VTAK): R&D Expense
$862.0K
Year ended 2025-12-31
$895.0K
Trailing 12 months to 2026-06-30
-48.7%
3-year compound annual growth
-37.4%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $862.0K | +216.9% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $272.0K | -42.7% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $475.0K | -92.6% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $6.39M | -47.8% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $12.25M | +36.8% | 2023-03-28, From 2021-01-01 |
| 2020-12-31 | $8.96M | +97.7% | 2022-03-24, From 2020-01-01 |
| 2019-12-31 | $4.53M | +63.2% | 2021-03-17, From 2019-01-01 |
| 2018-12-31 | $2.78M | -38.6% | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | $4.52M | n/a | 2019-03-15, From 2017-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $862.0K | +216.9% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $2.65M | +14.8% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.59M | -11.8% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $6.27M | +4.0% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.42M | -10.6% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | $7.52M | -17.4% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $23.94M | -11.5% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $10.0K | -35.0% |
Compare VTAK, HRGN, SINT, CODX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗